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Abstract
Background: Effects of respiratory viral infection on airway epithelium include airway hyper-responsiveness and
inflammation. Both features may contribute to the development of asthma. Excessive damage and loss of epithelial
cells are characteristic in asthma and may result from viral infection.
Objective: To investigate apoptosis in Adenoviral-infected Guinea pigs and determine the role of death receptor
and ligand expression in the airway epithelial response to limit viral infection.
Methods: Animal models included both an Acute and a Chronic Adeno-infection with ovalbumin-induced airway
inflammation with/without corticosteroid treatment. Isolated airway epithelial cells were cultured to study viral
production after infection under similar conditions. Immunohistochemistry, western blots and viral DNA
detection were used to assess apoptosis, death receptor and TRAIL expression and viral release.
Results: In vivo and in vitro Adeno-infection demonstrated different apoptotic and death receptors (DR) 4 and 5
expression in response to corticosteroid exposure. In the Acute Adeno-infection model, apoptosis and DR4/5
expression was coordinated and were time-dependent. However, in vitro Acute viral infection in the presence of
corticosteroids demonstrated delayed apoptosis and prolonged viral particle production. This reduction in
apoptosis in Adeno-infected epithelial cells by corticosteroids exposure induced a prolonged virus production via
both DR4 and TRAIL protein suppression. In the Chronic model where animals were ovalbumin-sensitized/
challenged and were treated with corticosteroids, apoptosis was reduced relative to adenovirus-infected or
corticosteroid alone.
Conclusion: Our data suggests that apoptosis of infected cells limits viral production and may be mediated by
DR4/5 and TRAIL expression. In the Acute model of Adeno-infection, corticosteroid exposure may prolong viral
particle production by altering this apoptotic response of the infected cells. This results from decreased DR4 and
TRAIL expression. In the Chronic model treated with corticosteroids, a similar decreased apoptosis was
observed. This data suggests that DR and TRAIL modulation by corticosteroids may be important in viral infection
of airway epithelium. The prolonged virus release in the setting of corticosteroids may result from reduced
apoptosis and suppressed DR4/TRAIL expression by the infected cells.
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Background
Viral respiratory tract infections have been implicated in
several ways with the pathogenesis of asthma. These
include the initial onset of asthma, particularly in the con-
text of post-bronchiolitis wheezing and asthma after hos-
pitalization for respiratory syncytcial virus (RSV) [1] and
in asthma chronicity and steroid resistance in Ad5 infec-
tions [2]. Ad5 infections are epidemiologically important,
and are estimated to cause ~5–10% of childhood respira-
tory infections [3]. Despite well-established epidemiolog-
ical associations between infections by viruses and the
development of asthma, the mechanisms by which these
pathogens contribute to the etiology of asthma are poorly
understood.
Apoptosis(programmed cell death) is a common cellular
response to virus infection [4]. Cell culture studies have
established that many common respiratory viruses can
induce apoptosis in epithelial cells [5,6]. Recent work has
demonstrated that viral infections can activate the tumour
necrosis factor (TNF)-related apoptosis-inducing ligand
(TRAIL) pathway, which leads to the selective apoptosis of
virus-infected cells [7]. TRAIL is the ligand for members of
the TNF-α death receptor (DR) family that includes mole-
cules such as DR4 and DR5 [8]. Presently there are limited
data available about the expression of TRAIL and DR in
normal or viral infected airway tissues. These studies were
undertaken to examine the role of Ad5 infection on
expression and function of TRAIL receptors DR4 and DR5.
The first objective of this study was to determine the base-
line and viral-induced expression of DR4/DR5 in Ad5
infected Guinea pig lungs and to correlate this expression
to apoptosis of the infected airway epithelial cells (AEC).
In some situations apoptosis can contribute to pathogen-
esis, but more typically it is an important factor in the host
defence mechanism which hastens the death of infected
cells to limit the replication and spread of virus [8]. In
healthy tissues, apoptosis is highly regulated to maintain
tissue integrity, function, and turnover of cells; therefore it
is generally viewed as being an anti-inflammatory process.
The role for apoptosis in the setting of viral infections con-
sequently may be a mechanism to limit the extent of infec-
tion, including inflammation.
Our next objective was to determine whether DR4/DR5
expression and apoptosis of infected epithelial cells has a
role in viral infections by Guinea pig airway epithelium
and how this may be altered by corticosteroid exposure.
This objective was based on reports regarding the rate of
viral detection as higher in asthmatic children than non-
asthmatics, symptomatic or not, suggesting a possible sus-
ceptibility to longer viral infections particularly in cases of
steroid resistance [9-11]. The present study was designed
to determine the role of apoptosis and DR expression in
models of airway inflammation and viral infection of air-
way epithelial cells. Our data suggest a role for DR in lim-
iting Acute virus infection through apoptosis of infected
cells. Modulation of DR and its ligand TRAIL expression is
effected by corticosteroids exposure and may be impli-
cated as a potential mechanism of viral persistence in the
airway epithelium. Steroid treatment prolonged virus
release from airway epithelial cells coordinate with the
reduced DR4 and TRAIL expression and altered the apop-
tosis of infected airway cells. Dysregulation of this apop-
totic process may contribute to airway remodeling.
Methods
Animals
Female Guinea pigs Cavia porcellus (Cam Hartley strain),
weighing 250–300 g (Charles River, ON, Canada) were
housed in polycarbonate cages fitted with high efficiency
particulate air filter covers. The animals were provided
care as approved by the University of British Columbia
Animal Care Committee, following published guidelines
of the Canadian Council on Animal Care.
Adenoviral infection
Acute model
Guinea pigs were anesthetized with 4% halothane bal-
anced with oxygen and were either adeno virus (Ad5)
infected via intranasal instillation or sham treated as pre-
viously described [12]. For the Acute model (Figure 1),
animals were sacrificed at 1, 3, 4 and 7 days post-infection
(dPi).
Chronic model: allergen-induced lung inflammation and Ad5 infection
For the Chronic model (Figure 1), three weeks after Ad5
infection, half of Ad5-infected and Sham-treated animals
were sensitized with ovalbumin (OVA) by exposure for 10
minutes to an aerosol spray of 1% OVA with 4% (vol/vol)
heat-killed pertussis vaccine in normal saline solution fol-
lowed by challenge consisted of delivering an aerosol
spray of 0.5% OVA (wt/vol) solution over a 5-minute
period. The remaining Sham animals were sensitized to
normal saline containing 4% heat-killed pertussis vaccine
and served as control animals for allergen sensitization
and challenged with normal saline solution. Diphenhy-
dramine (0.2 ml of 40 mg/ml in normal saline solution)
was administered intraperitoneally 1 h before each OVA
challenge to prevent anaphylactic shock. One group of
Ad5 infected/OVA sensitized/challenged animals were
injected with Budesonide (Bud) (20 mg/kg) intra-perito-
neal on 12 occasions over 16 days starting 24 hours before
the first allergen challenge. Three hours after the last OVA
challenge or saline exposure, Guinea pigs were sacrificed
with sodium pentobarbitol administered intra-perito-
neally. Lungs from the each treatment group were then
processed. Final groups included Sham control, Ad5, Bud,Respiratory Research 2006, 7:78 http://respiratory-research.com/content/7/1/78
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OVA, OVA+ Bud, OVA+ Bud+ Ad5 groups in the Chronic
model.
Tissue preparation and immunohistochemistry
The right lung was separated from the main stem bron-
chus, weighed and then inflated with 50% Optimal Cut-
ting Temperature compound (Tissue Tek, Miles Inc) in
PBS (pH 7.4). The inflated right lung lobe was cut into 3
blocks in the transverse plane, fixed in buffered 10% for-
malin and processed into paraffin. Immunohistochemical
(IHC) studies of paraffin-embedded formalin-fixed tissue
sections followed standard protocol of antigen retrieval
with autoclaving in 1X Citra buffer (BioGenex, CA) or
Trypsin digestion and blocking with Universal blocking
solution from DAKO (ON, Canada). Polyclonal rabbit
anti-DR4 and -DR5 antibodies (Cell Sciences Inc, MA)
and rabbit anti- PARP p85 fragment antibody (Promega,
MA) were used along with normal Rabbit IgG as negative
control to measure receptor expression and apoptosis
respectively. p85-PARP antibody is specific for the p85
fragment of PARP generated by caspase cleavage and pro-
vides a reliable measure of in situ apoptosis [13]. Antibody
binding was detected using avidin-biotin complex
method with naphthol AS-BI and New fuchsin as sub-
strate as per DAKO cytomation protocol. A semi-quantita-
tive scoring method was used by three independent
blinded observers to record DR4 and DR5 staining inten-
sity by scoring from scale of 0–4 (0- being no staining, and
4- being maximum staining) depending on staining
intensity in circular, medium sized airways. For p85-
PARP, the total number of positive cells in a minimum of
3 airways, scored by three independent observers, were
determined and scored as a percentage. The mean score
from 4 sections for each treatment was used to assign the
final score for the staining of all antibodies on all the sec-
tions.
Immunohistochemistry for E1A staining of Adeno-infected 
guinea pig lung tissue
Immunohistochemical studies of formalin-fixed paraffin
embedded tissue sections followed standard protocol of
antigen retrieval with autoclaving in 6M Urea and block-
ing with Universal blocking solution from DAKO (ON,
Canada). Anti-adenovirus E1A mouse monoclonal anti-
body (Calbiochem) was used along with normal mouse
IgG as negative control to detect E1A protein. Antibody
binding was detected using APPAP method (DAKO) with
naphthol AS-BI and New fuchsin as substrate as per
DAKO cytomation protocol without any counterstaining.
Guinea Pig Tracheal Epithelial Cell (GPTEC) isolation
Mid-cervical tracheas were dissected under sterile condi-
tions, and placed into 0.1% protease solution (type 25
from  Bacillus polymyxia Sigma-Aldrich ON, Canada) in
Study design for Ad5 infection and allergic inflammation in Cam Hartley Guinea pigs Figure 1
Study design for Ad5 infection and allergic inflammation in Cam Hartley Guinea pigs Animal model as modified 
from [12]. Animals were Ad5 infected or sham treated. In Acute model animals were sacrificed at d1–d7 post-infection. Other 
Ad5 infected or Sham treated animals were supported for 3 weeks post-infection (Chronic model). These Guinea pigs were 
then sensitized with OVA by aerosol administration at day 0 () followed by aerosol challenges as indicated (*). Steroids were 
given to a subset of these Guinea pigs at the indicated days (•) to permit resolution of the OVA-induced inflammation
* * ** * * * * * * **
Sacrifice d1- d7 (Acute Model)
Adenovirus or Sham infection
OVA or Saline sensitization
3 weeks day 0 7 14 21
• •• • •
Sacrifice (Chronic Model)
Figure 1
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HBSS for two hrs at 37°C[14]. Tracheal segments were
then transferred to plates containing Ham's F12 medium
(Sigma-Aldrich, ON) with 5% FCS. Epithelial cells were
dislodged using a micro-spatula, triturated through a
small-bore pipette tip and centrifuged at 850 × g for 11
min, then washed twice and GPTEC were maintained and
epithelial cell origin was confirmed as per protocol [15].
At 90–100% confluency cultured GPTEC were infected
with Ad5 at the multiplicity of infection of 10 (MOI 10).
Uninfected GPTEC served as a Sham control. Conditioned
media was collected daily to analyze the released viral par-
ticle production and fresh media was added.
Western blots
Western blots were done as previously described [16].
Membranes were probed for DR4, TRAIL and PARP pro-
teins using polyclonal anti-DR4 antibody (BD Pharmin-
gen), polyclonal anti-TRAIL antibody (eBiosciences) and
monoclonal anti -PARP antibody (BioMol Research labs)
respectively. Membranes were reprobed with an antibody
for β-actin (Sigma) when appropriate to control for equal
protein loading. Densitometry was performed to quanti-
tate expression.
Picogreen assay for nucleic acid quantitaion to determine 
viral particle number
The amount of Ad5 released into the conditioned media
was determined by the quantity of detected viral DNA
[17] using Picogreen (Invitrogen Canada, ON) as per kit
instructions. The viral DNA concentration was converted
to viral particles/ml (VP/ml) using the equation: VP/ml=
DNA conc. (ng/ml) X (2.6 × 108 VP/ml/10.3 ng/ml).
Adenoviral PCR
PCR was performed on the conditioned media collected
from the Ad5 infected GPTEC to confirm the detected
DNA was viral in origin. Primers were specific for Ad5
virus [F-primer: 5' – GCCGCGTGGTTTACATGCACATC 3'
and R-primer: 5' – CAGCACGCCGCGGATGTCAAA GT3']
[18].
Statistical analysis
Values are presented as means ± SE. The significance of
differences between means was assessed by Mann-Whit-
ney test with the level of significance set at p ≤ 0.05 to
compare the unpaired populations where sample size is
small and therefore Gaussian distribution cannot be
assumed. All statistical analyses were performed using
Prism 3 software.
Results
Guinea pig model of ovalbumin (OVA)-induced 
inflammation and corticosteroid treatment in 6-weeks Ad5 
infected Guinea pigs
Animals were created per model described in the Methods
and used by others [12]. The model of OVA-induced
inflammation generates changes in the airway compatible
to inflammatory diseases such as asthma.
Hematoxylin and eosin (H&E) stained Guinea pig lung
tissue sections demonstrated histological changes coordi-
nate with the various treatment groups (Figure 2). Sham
treated control lung sections demonstrated normal histol-
ogy (panel A). All shams (either single or in combination)
demonstrated no histological changes. Similarly there was
no change in DR expression; hence only one ''representa-
tive'' sham is shown. Adeno-viral infection generated an
eosinophilic infiltration and inflammation in the Acute
model (panel B). In the Chronic model of infection dam-
age in the alveolar parenchyma was noted along with
more extensive inflammation (panel C). Bud treatment
yielded Guinea pig lung sections with near normal histol-
ogy and no significant inflammation (panel D), whereas
inflammation and smooth muscle hypertrophy was
observed in the OVA-sensitized/challenged lung sections
(panel E). OVA+Bud treated Guinea pig lung section had
little eosinophilic infiltration, and no smooth muscle
hypertrophy compared to OVA alone group (panel F). The
combination of Ad5+OVA+Bud in the Guinea pig lung
demonstrated damage in the alveolar parenchyma,
inflammation and smooth muscle hypertrophy (panel
G). Viral persistence in terms of E1A protein expression
was detected in the Chronic model of Guinea pig airway
epithelial cells as indicated by pink staining of the nuclei
(panel H) compared to no stain for the isotype control
(panel I). Arrows indicated positive staining for E1A pro-
tein in the airways.
Apoptosis and DR4/DR5 expression in acute model of 
adenoviral infection
Both DR4 and DR5 were expressed in the airway epithe-
lium of Guinea pigs after viral infection and OVA sensiti-
zation and challenge as demonstrated by representative
images of DR4, DR5 and p85-PARP immunohistochemi-
cal staining (Figure 3). Apoptosis and death receptor
expression were observed as a result of Acute Ad5 infec-
tion of the airway epithelium. For this model lung tissues
were collected up to 7 days after the initial Ad5 infection
and assessed for p85-PARP staining as a marker of apop-
tosis. Positive staining for the p85 fragment (Figure 4A)
increased from 1 day post-infection (dPi) (3.7% ± 2.4%)
to 4 dPi (8.3% ± 2.6%) and reduced by 7 dPi (3.2% ±
1.1%). There was a significant increase (* p < 0.05) in
apoptosis for 1 dPi, 3 dPi and 4 dPi samples compared to
uninfected Sham control. After its peak expression at 4Respiratory Research 2006, 7:78 http://respiratory-research.com/content/7/1/78
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dPi, apoptosis decreased significantly by 7 dPi († p < 0.05)
compared to 4 dPi and this 7 dPi apoptosis was not signif-
icantly different from Sham (Figure 4A).
Both DR4 and DR5 were detected in the Acute infection.
No DR4 expression was detected at baseline in the Sham
controls. However, after Acute Ad5 infection DR4 expres-
sion peaked at 3 dPi (1.3 ± 0.7) and returned towards
Hematoxylin and eosin-stained representative lung sections from the Guinea pig models Figure 2
Hematoxylin and eosin-stained representative lung sections from the Guinea pig models. Guinea pig lungs sec-
tions from sham control (A); lung section after 7 days post-Ad5 infection (Acute model) (B); and after 6 weeks post-Ad5 infec-
tion (Chronic model) (C). Arrow indicate regions of inflammation and eosinophilic infiltration, also noted in the Chronic model 
is the damage to the alveolar parenchyma as indicated by *. Guinea pig airways showing normal histology in Budesonide (Bud) 
treated lungs (D), whereas ovalbumin (OVA) sensitized/challenged lung sections show airway inflammation and smooth muscle 
hypertrophy (E). OVA+Bud treated lung section had little eosinophilic infilteration, and no hypertrophy (F). The 
Ad5+OVA+Bud treated lungs (G) demonstrate damage in the alveolar space, inflammation and alterations of other airway wall 
components. E1A protein was detected in chronically infected lung sections, arrows indicate positive staining for E1A protein 
in the nuclei of airway epithelial cells (H) when compared to no staining for isotype control (I). Scale bar represent 100 µm in 
panels A through G, and 10 µm for panel H and panel I.Respiratory Research 2006, 7:78 http://respiratory-research.com/content/7/1/78
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baseline at 7 dPi (Figure 4B). DR5 was expressed in the
Sham control and from 1–7 dPi (Figure 4B). This
increased expression is noted after Ad5 infection, and
maximal expression occurred at 3 dPi. The apoptosis
observed in the Acute model was in concordance with the
DR4/DR5 expression (Figure 4A/4B). The apoptotic
response lags behind the increased DR4/DR5 expression,
as might be expected. When the DR4/5 expression was
correlated with apoptosis at the succeeding time point,
there was a significant positive correlation (p = 0.01 for
DR4 vs. apoptosis and p = 0.0001 for DR5 vs. apoptosis).
This data suggests that apoptosis in Acute vial infection
may be mediated by DR4/DR5 signaling.
In vitro apoptosis and death receptor expression after 
acute Ad5 virus infection
From the Acute animal studies we observed that apoptosis
of the viral infected cells may be a mechanism to limit the
infection. DR4 and DR5 were noted to be expressed and
regulated in response to the Acute viral infection. To vali-
date this model we established a cell culture system using
GPTEC isolated from the Cam Hartley Guinea pigs.
GPTEC were infected with Ad5 virus at MOI10 to effect
maximal infection of ~20% of the cultured cells. At 1 dPi
(Ad5 or Sham) the GPTEC were treated with +/- Bud to
examine the effect of corticosteroids. Untreated cultured
cells served as Sham controls. As determined by detection
of p85-PARP protein expression, apoptosis increased after
Ad5 infection when compared to uninfected Sham con-
trols (Figure 5A). The detection of the p85 fragment at 4
dPi was higher than the uninfected cells (0.9 ± 0.01 vs. 0.6
± 0.02; * p ≤ 0.05). Bud-treated GPTEC had the highest
p85-PARP detection (1.8 ± 0.07 Bud 2d, 1.6 ± 0.05 Bud
3d, and 1.8 ± 0.1 Bud 4d) and all time points were signif-
icantly increased from Sham (* p ≤ 0.05). This is consist-
ent with corticosteroid-induced apoptosis of AEC as
demonstrated previously [16] and is independent from
death receptor expression and function. The Ad5+Bud
group demonstrated a reduction in apoptosis († p ≤ 0.05)
when compared to Bud alone. The early trend of apopto-
sis in Acute Ad5 infection was absent in the Ad5+Bud
group, although by day 4 (4 dPi) apoptosis was signifi-
cantly increased (1.2 + 0.03 * p ≤ 0.05) compared to Sham
(Figure 5A). Overall with a low infection rate the absolute
changes in detected apoptosis may remain low; however
any change in the timing of apoptosis could have signifi-
cant effects later. To observe the affect of Bud exposure on
the Ad5 infection and related apoptosis, p85 affect for
both Ad5 and Ad5+Bud groups was normalized to the
baseline (Ad5 1 dPi). Table 1 demonstrates that Ad5 infec-
tion demonstrated an "early" initiation of apoptosis:
11.3% increase at 2 dPi, 18.2% at 3 dPi and 57% by 4 dPi,
whereas Ad5+Bud demonstrated a "late" initiation of
apoptosis effect starting at 7% at 2 dPi, only 1.6% at 3 dPi
and 107% at 4 dPi. Overall apoptosis is similar between
Ad5 and Ad5+Bud; however the trend for increasing apop-
Representative images of airway epithelial immunostaining of Cam Hartley Guinea pigs Figure 3
Representative images of airway epithelial immunostaining of Cam Hartley Guinea pigs Semi-quantitative scoring 
was utilized to determine the expression for DR4(A), DR5 (C) and p85-PARP (E) in immunohistochemically stained lung sec-
tions. Panels B, D and F were the isotype controls for the respective antibodies. Arrows indicate the stained epithelial cells. 
Scale bar represent 10 µm in panels A through F.Respiratory Research 2006, 7:78 http://respiratory-research.com/content/7/1/78
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tosis over 4 days after Ad5 infection was significantly
altered. This alteration by Bud in the pattern of apoptosis
of Ad5 infected GPTEC is in association with Bud sup-
pressing DR4 and TRAIL expression when compared to
Ad5 alone (Figure 5B, 5C).
Our Guinea pig Acute infection model, suggested a role
for both DR4 and DR5 in the modulation of apoptosis.
We focused on DR4 as a major candidate in our in vitro
Ad5-infection model as the magnitude of change in DR4
expression was much higher than that of DR5. There was
baseline DR4 expression in the uninfected Sham controls
that was significantly less than the Ad5 infected cells for
all time points. Figure 5B demonstrates that DR4 protein
was significantly increased (* p < 0.05) in Ad5 alone and
Bud alone groups from Sham baseline at 2–4 dPi. The Ad5
infected group demonstrated the highest DR4 expression
at 4 dPi (1.5 ± 0.1). DR4 expression was altered in the
presence of corticosteroids. Bud (1 µM) was added to the
cultured GPTEC at 1 dPi to model the treatment for the
resolution of the virus-induced inflammation. As demon-
strated in Figure 5B there is an initial increase in DR4
expression after 2d of Bud exposure (1.16 ± 0.09 vs. 0.68
+ 0.02 p < 0.05) however the magnitude of increase in
DR4 expression did not persist over time (3d 0.93 ± 0.09
vs. Sham * p ≤ 0.05; 4d 0.83 ± 0.03 vs. Sham p < 0.05),
and at all time points expression was greater than Sham (*
p < 0.05). Ad5+Bud demonstrated a significant reduction
in DR4 expression when compared to either Ad5 alone (†
p < 0.05) or Bud alone (§p < 0.05). The DR4 expression in
Ad5+Bud was not different from the Sham control. The
individual challenges of either Ad5 or Bud increased DR4
expression within 1d; however the combination was not
synergistic.
TRAIL is the ligand for the receptors DR4 and DR5. TRAIL
protein expression was determined in the total protein
lysates obtained from the Ad5, Bud and Ad5+Bud treated
GPTEC. Ad5 alone treated cells demonstrated the signifi-
cant increase in TRAIL expression (Figure 5C) at 2–3 dPi
increasing further at 4 dPi (0.75 ± 0.05 * p ≤ 0.05) which
mirrors the effect on DR4 expression. TRAIL expression
was not increased by Bud alone and Bud+Ad5 treatments
demonstrated a significant reduction in TRAIL expression
at day 3 and day 4 when compared to Ad5 alone († p ≤
0.05). This alteration by Bud in the pattern of apoptosis of
Ad5 infected GPTEC is in association with Bud suppress-
ing both DR4 and TRAIL expression when compared to
Ad5 alone.
Table 1: 
Groups Day 2 Day 3 Day 4
Ad5 11.3 18.2 56.9
Ad + Bud 6.9 1.6 107
Acutely infected GPTEC demonstrate apoptosis coordinate with DR4 and DR5 expression Figure 4
Acutely infected GPTEC demonstrate apoptosis coordinate with DR4 and DR5 expression Semi-quantitative 
scoring was utilized to determine the expression of p85-PARP, DR4 and DR5 in the Guinea pig lung sections by immunohisto-
chemistry. p85-PARP was significantly higher in 1 -4 dPi lung sections compared to Sham controls, peaked at 4 dPi and decreas-
ing significantly by 7 dPi (Figure 4A). This trend in apoptosis in the Acute model was coordinate with the changes in DR4 and 
DR5 expression (Figure 4B). * p < 0.05 compared to Sham and †p < 0.05 compared to 4 dPi.
Figure 4B
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in vitro model of Ad5-infected GPTEC demonstrate p85-PARP, DR4 and TRAIL expression Figure 5
in vitro model of Ad5-infected GPTEC demonstrate p85-PARP, DR4 and TRAIL expression. Western blotting of 
total protein lysates collected from Ad5 infected GPTEC demonstrated elevated apoptosis in Ad5 infected cells by 4 dPi and 
Bud treated cells from 2- 4 dPi compared to Sham cells. Ad5+ Bud group had significantly less apoptosis compared to Bud 
alone. The inset shows protein bands corresponding to p85-PARP and house keeping β-Actin protein for respective groups 
(Figure 5A). Ad5 induced apoptosis corresponds to DR4 expression (Figure 5B) and to DR ligand TRAIL (Figure 5C). Ad5+Bud 
group demonstrated suppressed DR4 and TRAIL protein expression compared to Ad5 alone and Bud alone for respective 
treatment days (Figure 5B, 5C), * p < 0.05 compared to Sham, §p < 0.05 compared to Bud alone, † p < 0.05 compared to Ad5 
alone.
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Viral particle release by Ad5 infected GPTEC in vitro
Apoptosis of viral infected AEC could limit ongoing infec-
tion and the resulting inflammation. Infected GPTEC 1
dPi were divided into two pools, one was treated with the
corticosteroid Bud, the other not. As demonstrated in Fig-
ure 6 viral particle (VP) release into the conditioned
media peaked at 2 dPi and then significantly decreased by
4 dPi (2 dPi, 11 × 106 ± 1.8 × 106 vs. 4 dPi 3.8 × 10 6 ± 1.3
× 106 §p < 0.05). In contrast, Ad5 infection treated with
Bud 1dPi (Ad5+Bud) demonstrated a marked suppression
of VP release within 24 hrs of corticosteroid exposure (4.9
× 106 ± 1.2 × 106* p < 0.05). With in the first 24 h of Bud
treatment (2 dPi)VP released by the Ad5+Bud group was
not different from the untreated pool at 1 dPi. In the sub-
sequent two days VP detection continued to increase in
the Ad5+Bud group while the Ad5 alone group demon-
strated a significant reduction in VP release § p < 0.05. By
4 dPi there was significantly more viral DNA particles
released per day into the media in the Bud treated group
when compared to Ad5 alone (8.3 × 106 ± 0.7 × 106 vs. 3.8
× 106 ± 1.3 × 106 † p < 0.05). This increase in VP release is
coordinate with the altered timing of apoptosis of the Ad5
infected GPTEC in the Ad5+Bud group (Figure 5A). The
inset shows amplification of DNA from the conditioned
media. Amplification is noted only for Ad5 and not
housekeeping genes common to Guinea pigs and human.
This result confirmed that the DNA detected by the
picogreen assay was indeed Ad5 specific and was not con-
tamination from GPTEC DNA.
DR4/DR5 expression in the Chronic model of Guinea pig 
ovalbumin (OVA) induced inflammation and corticosteroid 
treatment
Apoptosis and DR4 expression of airway epithelium were
associated in the Acute model of viral infection and also
demonstrated in the in vitro GPTEC model. There was sup-
pressed apoptosis and DR4 and TRAIL expression as a
result of Bud treated Ad5 infected cells when compared to
Ad5 infection alone. We went on to investigate a model of
allergic airway inflammation where persistent viral infec-
tion may contribute significantly to the Chronic airway
remodeling identified in this condition. The identification
of apoptotic cells and death receptor expression was deter-
mined as for the Chronic model (Figure 7A, 7B). Apopto-
sis, as detected by positive staining for the p85 fragment
of PARP (Figure 7A) was observed for all the groups except
Sham control. Persistent Ad5 infection demonstrated the
greater extent of apoptosis (6.1% + 0.78%), followed by
Bud (3.9% + 0.48%) and OVA (1.8% + 0.21%) as individ-
ual challenges. Bud treatment of OVA- allergic inflamma-
tion (OVA+Bud) demonstrated decreased apoptosis
compared to Bud only (Figure 7A). Airway epithelial cells
positive for p85-PARP were significantly reduced in the
Ad5+OVA+Bud group (2.0% + 0.6%) when compared to
the Ad5 group (* * p < 0.005)(Figure 7A). A coordinate
and consistent response of DR expression to apoptosis
was observed only for the groups not infected with Ad5.
Sham control had 0% apoptosis and no detectable DR4;
OVA and OVA+Bud had increasing apoptosis and DR4
expression. The apoptosis generated by Bud alone is DR
independent and thus the reduced DR expression is con-
sistent.
DR4 was not detected at baseline where DR5 was detected
at baseline. OVA, Bud, Ad5 individual treatments
increases DR4 compared to Sham control, whereas DR5 is
unchanged by OVA and decreased by Bud and Ad5 (Figure
7B). OVA+Bud group is unchanged from OVA alone for
both DR4 and DR5. DR4 expression is less in
Ad5+OVA+Bud compared to OVA+Bud but greater than
Ad5 alone. DR5 expression has returned to baseline
expression. This demonstrates that each receptor is regu-
lated differently by these challenges.
Prolonged viral particle release into culture media is coordi- nate with exposure to corticosteroids Figure 6
Prolonged viral particle release into culture media is 
coordinate with exposure to corticosteroids Picogreen 
assay performed on the condition media collected from Ad5 
infected GPTEC with/out Bud exposure show an early 
reduction in viral particle release as determined by the 
detection of Ad5 DNA in the conditioned media. However 
beyond this initial 24 h period of treatment the detection of 
viral DNA continued to increase while in the untreated Ad5 
infected GPTEC the detection of viral DNA significantly 
reduced. The insert demonstrates amplification of WtAd5 
gene (Lane 1), and housekeeping β-actin (Lane 2) from the 
conditioned media, and WtAd5 gene (Lane 3), and human β-
actin (Lane 4) from the Sham infected human airway epithe-
lial cells. This demonstrates that amplified signal in Lane 1 is 
specific from the viral DNA and not from the epithelial cells 
in the supernatant. * p < 0.05 compared to Ad5+Bud 2 dPi, 
§p < 0.05 compared to Ad5 2dPi and † p < 0.05 compared to 
Ad5+Bud 4 dPi.
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What is most interesting is the reduced detection of apop-
totic AEC in the Ad5+OVA+Bud group. The Ad5 alone has
extensive apoptosis with a relatively small but significant
increase in DR4 expression relative to baseline and
reduced DR5. This suggests the relative importance of
DR4 in viral-induced AEC apoptosis. OVA+Bud demon-
strate increased DR4 expression and still significant apop-
tosis relative to Sham baseline. However Ad5+OVA+Bud
demonstrates significant increases in both DR4 (0.67 ±
0.22 * p < 0.05) and DR5 (2.83 ± 0.11 * p < 0.05) expres-
sion relative to Ad5 alone, but detectable apoptosis is
markedly lower than what be expected. As demonstrated
in the Acute model, decreased expression of TRAIL the lig-
and for DR4/ DR5 may account for this effect.
Discussion
In this study our objective was to determine what role
apoptosis and death receptor expression may play in viral
infection of AEC. Viral production from infected AEC may
be limited by apoptosis, and if dysregulated, in disease
states such as asthma, this may lead to longer viral persist-
ence and inflammation. Insight into possible mecha-
nisms for the persistent inflammation would help to
develop new therapeutic targets. We studied two models
of Acute viral infection and one of asthma post-viral infec-
tion of the AEC. This report is the first demonstrating that
in the setting of corticosteroid treated inflammation,
apoptosis might be dysregulated leading to longer viral
persistence. This effect may be mediated by modulation of
DR4 and TRAIL regulation in AEC in response to corticos-
teroid exposure. This resulting apoptosis of AEC suggest a
mechanism to limit the viral infection.
Reported differences in DR4 and DR5 expression prima-
rily depend on tissue origin [19-21]. The role for this
altered regulation of DR expression in pulmonary tissue
and in particular in asthmatics as it relates to epithelial
damage, apoptosis, and persistence of viral infection and
inflammation is unknown. If DR4 expression is responsi-
ble for limiting Acute viral infection by being pro-apop-
totic in a model of Acute viral infection of AEC we would
expect that DR4 expression and apoptosis would be
increased. In Guinea pigs the airway epithelium of unin-
fected, unsensitized animals does not express immunore-
active DR4 protein (Figure 4B). In contrast, in response to
Acute Ad5 infection, DR4 expression in Guinea pig lung
tissues increases and is maximal at 3 dPi returning to base-
line expression at 7 dPi (Figure 4B). Coordinate with the
DR4 expression post-Ad5 infection, apoptosis demon-
strated a similar trend as detected by cleaved p85-PARP.
The increased apoptosis is compatible with DR4 expres-
sion as an initiating factor in Ad5 infection as the detecta-
ble DR4 expression precedes apoptosis detection. This is
in accordance with the other reports that the death recep-
tor system plays an important role in the elimination of
virus-infected cells [7,19,22,23]. Cells infected by human
cytomegalovirus, Ad5, reovirus, measles, or HIV demon-
strate increased DR4 and DR5 expression rendering them
more sensitive to TRAIL-induced apoptosis by autocrine
or T-cell derived TRAIL This indicates that DR4 expression
Guinea pig AEC apoptosis and DR expression as detected by Immunohistochemistry of the Chronic model of Guinea pig viral  infection and airway inflammation Figure 7
Guinea pig AEC apoptosis and DR expression as detected by Immunohistochemistry of the Chronic model of 
Guinea pig viral infection and airway inflammation Semi-quantitative scoring was utilized to determine the expression 
of p85-PARP, DR4 and DR5 in the Guinea pig lung sections by immunohistochemistry. Significant reduction in the detection of 
p85-PARP for Ad5+OVA+Bud group (** p < 0.005) was observed when compared to Ad5 alone group (Figure 7A). However, 
DR4/DR5 expression for Ad5+OVA+Bud group was higher compared to Ad5 alone group * p < 0.05 (Figure 7B).
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corresponds to Acute viral infection leading to apoptosis
of infected cells. We confirmed the role for DR4 and
TRAIL in an in vitro model. Our data demonstrated that in
the situation of only Acute Adeno-infection, cultured
GPTEC establish an apoptotic pathway via increased
receptor (DR4) expression and its ligand (TRAIL) expres-
sion, leading to clearance of virally infected cells (Figures
5A, 5B, 5C).
The effects of corticosteroid exposure on Ad5 infection of
AEC were investigated further in a cell culture model to
determine what role altered AEC apoptosis would have on
viral particle production. GPTEC were treated with Bud
with or without Ad5 infection. Some DR4 protein expres-
sion was observed at baseline for the Sham controls, likely
a consequence of epithelial disruption and subsequent
culturing but was significantly higher in the Ad5 infected
GPTEC (Figure 5B). This is coordinate with the Ad5 induc-
tion of DR4 expression in the Acute animal model. Bud
alone did not change DR4 expression from baseline but
when Bud was added to Ad5 infected cultures DR4 expres-
sion was markedly reduced. Bud-induced apoptosis dem-
onstrated the expected steroid effect [24,16] and showed
that it is death-receptor independent. However, Ad5+Bud
demonstrated suppressed apoptosis and less DR4 expres-
sion compared to Bud treatment or Ad5 infection alone.
Apoptosis observed as p85-PARP protein expression was
less in the early stages of treatment, leading to delayed
viral particle production which was compatible with our
VP production data in Figure 6. Ad5+Bud group demon-
strate "early" vs. "later" effect of induced-apoptosis via
suppressed DR4 expression in the setting of corticoster-
oids. The "shape" of the apoptosis curve as represented by
p85-PARP protein in the Ad5 group demonstrate that
apoptosis started early is consistent with increased DR4
expression and correlates to early viral particle release
which then decreases over time as shown in Figure 6.
Ad5+Bud group showed late apoptosis with extended
time during which VP release was also detected (Figure
5A, Figure 6). Since the DR4 expression was suppressed in
the Ad5+Bud (Figure 5B) group, the maximum p85 pro-
tein expression at 4 dPi might be a result of DR-independ-
ent Bud effect.
Table 1 data shows that "net" apoptosis by day 4 is
approximately the same but timing to onset this apoptosis
is altered by Bud. This change in DR4 expression by corti-
costeroid treatment of viral-infected AEC and the resulting
altered regulation of apoptosis would have effects on viral
clearance and the resulting inflammation. Initial reduc-
tion in VP release in Ad5+Bud group at 2 day compared to
Ad5 alone is compatible clinically with corticosteroids
treatment used to treat bronchiolitis associated inflamma-
tion. This however may be at the expense of altered apop-
totic response to viral infection resulting in longer VP
production.
The combination of Ad5+OVA+Bud in the animal model
generated a condition where apoptosis was decreased
(Figure 7A) relative to what was expected considering the
response to Ad5 infection in the Acute model (Figure 4A).
However, the mechanism established in the Acute animal
model (Figure 4A, 4B) and also in the in vitro Adeno infec-
tion of GPTEC (Figures 5A, 5B) was altered in the case of
allergic airway inflammation and corticosteroid exposure
where both DR4 and apoptosis are markedly decreased.
While there was no change in the DR5 expression in the
Guinea pigs of allergic airway inflammation (Figure 7B),
DR4 demonstrated a regulation of expression in response
to allergic inflammation, viral infection and corticoster-
oid treatment. DR4 expression was not detected in the
control, but was observed in the Ad5 infected/ sham sen-
sitized/challenged group. OVA-sensitized group as allergic
model and Bud treatment also demonstrated increase in
DR4 expression. This increase may be in response to the
OVA-induced airway inflammation, which produces an
"asthmatic" phenotype in Guinea pigs characterized by
non-specific airway hyper-reactivity and airway eosi-
nophilia [25]. However this increase was not synergistic in
combination with Bud and Ad5 treatment. Therefore,
DR4 expression and resulting apoptosis may be a mecha-
nism to limit epithelial hyperplasia and metaplasia that
can occur in chronic airway inflammation. Uninfected,
OVA-sensitized animals have an increase in DR4 and
cleaved p85-PARP detection in AEC. In vivo DR4 expres-
sion as detected in the Ad5 group did not correspond in
time to observed apoptotic effect. This effect of time is
identified in the in vitro GPTEC model too (Figures 5A,
5B). DR expression should correlate to apoptosis and in
our model allergic airway inflammation induces not only
DR4 expression but the resultant apoptosis of AEC. When
the OVA-sensitized animals were treated with the corticos-
teroid Bud to reduce the eosinophilic inflammation, DR4
expression remained constant relative to that detected in
OVA alone. However, the detection of apoptotic AEC by
p85-PARP increased dramatically (Figure 7A). The
increased apoptosis in the OVA+Bud group reflects the
corticosteroid induced apoptosis of AEC as shown previ-
ously [24,16] as additive to that generated by inflamma-
tion alone. If the mechanism to control AEC survival is
dysregulated or disrupted by certain treatments this may
contribute to altered cell numbers or other specific struc-
tural changes in the airway.
Cells undergo programmed cell death as an initial
response to infections by pathogens, such as viruses. The
cellular response against viral infection includes produc-
tion of inflammatory and anti-viral cytokines, as well as
the induction of apoptosis. Many viruses have evolvedRespiratory Research 2006, 7:78 http://respiratory-research.com/content/7/1/78
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mechanisms that inhibit inflammation and prevent apop-
tosis and, as a consequence, are able to establish a
Chronic phase [26]. DR4 regulation can be the natural
mechanism pre-disposing the infected cells to undergo
apoptosis. Balance between this pro-apoptotic effect to
limit infection in the host and the natural anti-apoptotic
viral response will determine the clearance of viral-
infected cells and persistence of inflammation. In the ani-
mal model, another set of Guinea pigs were Ad5 infected
followed by OVA-sensitization and corticosteroid-treat-
ment. This set of experiments demonstrated that DR4
expression is dysregulated by the combination of allergic
airway inflammation and corticosteroid treatment in the
setting of Ad5 infection. Whereas OVA alone or OVA+Bud
increase both apoptosis of AEC (Figure 7A) and DR4
expression (Figure 6B) relative to baseline, the addition of
Ad5 suppressed apoptosis and DR4 expression from that
detected in OVA+Bud. This reduction in AEC apoptosis
could contribute to viral-induced airway inflammation.
Corticosteroids are used clinically to reduce inflammation
in viral bronchiolitis and asthma. Reduced viral clearance
characteristic in asthmatics [27] may be explained by the
corticosteroid use. Recently, decreased apoptosis has been
reported in rhinovirus-infected asthmatic airway epithe-
lial cells [28] suggesting an additional innate defect in
viral-induced apoptosis of AEC that may also contribute
to the asthmatic condition. These are important points as
other studies report contradictory results regarding the
extent of any anti-inflammatory benefit from corticoster-
oid therapy. The steroid effects may be dependent on the
type of infecting virus [29,30]. Figure 6 demonstrates
decreased viral production by infected AEC when treated
with corticosteroid only after one day of corticosteroid
treatment of the infected culture. Ad5 particle production
increased over the subsequent number of days. After 3
days of corticosteroid treatment the GPTEC infected with
Ad5 were producing more viral particles than the
untreated cultures. The supposed benefit of corticosteroid
treatment for viral bronchiolitis may then only be recog-
nized with the first day of treatment and thereafter viral
production increases and persists. To what extent this ster-
oid effect contributes to persistent or excessive airway
inflammation remains to be determined. These results
suggest that DR regulation may be affected by the presence
of steroids in the setting of adenoviral infection. To our
knowledge, no study has investigated whether viral-
induced epithelial damage is improved or worsened by
corticosteroid treatment. The overall effects of corticoster-
oids and how they contribute to the airway remodeling is
beyond scope of this study but should be considered in
future studies particularly in the setting of viral exacerba-
tions to airway inflammation.
Conclusion
Our study concludes that in normal AEC, apoptosis is a
mechanism to limit viral particle release. DR4 is regulated
in response to viral infection. DR4 and TRAIL expression
is coordinated with an increase in AEC apoptosis in the
Acute model of viral infection and corresponds to virus
particle release. However, in the setting of airway inflam-
mation or in the presence of corticosteroids, this mecha-
nism limiting viral particle release is disrupted. Further
understanding the mechanism of airway epithelial
response to viral infection in the setting of allergic inflam-
mation or steroid exposure would suggest changes in our
present therapies for airway inflammation.
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